Eli Lilly’s idiopathic pulmonary fibrosis deal with Mediar is centered around MTX-463, an anti-WISP1 antibody that early ...
Eli Lilly has been operating a global capability center (GCC) in Bengaluru, India. | For nearly a decade, Eli Lilly has been operating a global capability center (GCC) in Bengaluru, India. Now, with ...
Forty submissions, weeks of polls and several thousand votes from Herald-Leader subscribers have finally brought us to this ...
Though we’re well into the winter season, Lilly Pulitzer always finds a way to get us excited for spring and summer. The ...
Patricia Clarkson is forgettable in tonally confusing 'Lilly,' full of intrusively edited archival material and curious ...
Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in ...
Good morning! Meta's elimination of fact-checking opens the door to misogynistic speech, Jane Fraser faces a test at Citi, ...
In February 2016, a gangland murder in broad-daylight shocked the nation of Ireland, and it involved the uncle of a young man ...